0

524602

BANDARAM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BANDARAM PHARMA PACKTECH LIMIT Share Price Today

Investment Returns

Over 1 Month -0.63% Over 3 Months 7.60% Over 6 Months 14.15% Over 1 Year -25.91%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BANDARAM PHARMA PACKTECH LIMIT fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 53.20
  • P/E Ratio (TTM) -46.23
  • Beta 0.40
  • Book Value / share 12.73
  • Return on equity 1.15%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.33
info icon alternate text

BANDARAM PHARMA PACKTECH LIMIT Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 8.20
Operating Expense 8.53
Net Profit -0.33
Net Profit Margin (%) -4.02
Earnings Per Share (EPS) -0.18
EBITDA -0.33
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 1.68
Operating Expense 1.89
Net Profit -0.21
Net Profit Margin (%) -12.50
Earnings Per Share (EPS) -0.12
EBITDA -0.21
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.33
Operating Expense 0.68
Net Profit -0.35
Net Profit Margin (%) -106.06
Earnings Per Share (EPS) -0.29
EBITDA -0.35
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.76
Operating Expense 1.03
Net Profit -0.27
Net Profit Margin (%) -35.52
Earnings Per Share (EPS) -0.22
EBITDA -0.27
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 3.71
Operating Expense 3.75
Net Profit 0.04
Net Profit Margin (%) 1.07
Earnings Per Share (EPS) 0.04
EBITDA 0.06
Effective Tax Rate (%) 16.66
Particulars MAR 2026 (Values in Cr)
Revenue 10.96
Operating Expense 12.13
Net Profit -1.16
Net Profit Margin (%) -10.58
Earnings Per Share (EPS) -0.64
EBITDA -1.16
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 12.23
Operating Expense 12.14
Net Profit 0.14
Net Profit Margin (%) 1.14
Earnings Per Share (EPS) 0.12
EBITDA 0.20
Effective Tax Rate (%) 26.31
Particulars MAR 2024 (Values in Cr)
Revenue 14.84
Operating Expense 14.69
Net Profit 0.13
Net Profit Margin (%) 0.87
Earnings Per Share (EPS) 0.11
EBITDA 0.19
Effective Tax Rate (%) 23.52
Particulars MAR 2023 (Values in Cr)
Revenue 10.09
Operating Expense 9.82
Net Profit 0.20
Net Profit Margin (%) 1.98
Earnings Per Share (EPS) 0.68
EBITDA 0.27
Effective Tax Rate (%) 25.92
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.01
Net Profit -0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 10.54
ROE % 7.94
ROCE % 8.47
Total Debt to Total Equity 1.18
EBITDA Margin 7.90
Particulars MAR 2024 (Values in Cr)
Book Value / Share 10.23
ROE % 12.37
ROCE % 10.15
Total Debt to Total Equity 1.72
EBITDA Margin 8.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.28
ROE % 8.44
ROCE % 4.40
Total Debt to Total Equity 4.61
EBITDA Margin 7.15
Particulars MAR 2025 (Values in Cr)
Book Value / Share 10.09
ROE % 1.15
ROCE % 1.37
Total Debt to Total Equity 0.14
EBITDA Margin 1.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 10.17
ROE % 1.70
ROCE % 1.73
Total Debt to Total Equity 0.29
EBITDA Margin 1.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.25
ROE % 6.60
ROCE % 5.16
Total Debt to Total Equity 0.73
EBITDA Margin 2.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.97
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.17
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -10.18
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.11
Total Assets 38.91
Total Liabilities 38.91
Total Equity 15.82
Share Outstanding 1
Price to Book Ratio 4.60
Return on Assets (%) 2.55
Return on Capital (%) 3.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 32.05
Total Liabilities 32.05
Total Equity 15.06
Share Outstanding 1
Price to Book Ratio 3.64
Return on Assets (%) 2.95
Return on Capital (%) 3.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 20.17
Total Liabilities 20.17
Total Equity 5.13
Share Outstanding 0
Price to Book Ratio 7.12
Return on Assets (%) 0.70
Return on Capital (%) 0.73
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 19.20
Total Liabilities 19.20
Total Equity 12.10
Share Outstanding 1
Price to Book Ratio 4.60
Return on Assets (%) 0.72
Return on Capital (%) 0.9
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 13.35
Total Liabilities 13.35
Total Equity 12.20
Share Outstanding 1
Price to Book Ratio 3.64
Return on Assets (%) 0.96
Return on Capital (%) 1.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 8.26
Total Liabilities 8.26
Total Equity 3.07
Share Outstanding 0
Price to Book Ratio 7.12
Return on Assets (%) 2.46
Return on Capital (%) 2.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.08
Total Assets 2.99
Total Liabilities 2.99
Total Equity 2.98
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -0.33
Return on Capital (%) -0.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 1.26
Total Liabilities 1.26
Total Equity -2.31
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -2.50
Return on Capital (%) 3.65
Particulars MAR 2025 (Values in Cr)
Net Income 1.31
Cash from Operations -4.60
Cash from Investing -0.07
Cash from Financing 5.08
Net change in Cash 0.07
Free Cash Flow -4.52
Particulars MAR 2024 (Values in Cr)
Net Income 1.18
Cash from Operations -3.91
Cash from Investing -1.57
Cash from Financing 5.59
Net change in Cash -0.11
Free Cash Flow -3.73
Particulars MAR 2023 (Values in Cr)
Net Income 0.32
Cash from Operations -1.09
Cash from Investing -5.30
Cash from Financing 4.46
Net change in Cash -1.93
Free Cash Flow 1.69
Particulars MAR 2025 (Values in Cr)
Net Income 0.18
Cash from Operations -3.20
Cash from Investing 0.00
Cash from Financing 3.22
Net change in Cash -0.02
Free Cash Flow -3.20
Particulars MAR 2024 (Values in Cr)
Net Income 0.17
Cash from Operations -3.21
Cash from Investing -1.40
Cash from Financing 4.61
Net change in Cash -0.04
Free Cash Flow -3.21
Particulars MAR 2023 (Values in Cr)
Net Income 0.27
Cash from Operations -3.86
Cash from Investing -2.53
Cash from Financing 4.40
Net change in Cash -1.99
Free Cash Flow -3.84
Particulars MAR 2022 (Values in Cr)
Net Income -0.01
Cash from Operations 2.91
Cash from Investing -1.55
Cash from Financing 0.72
Net change in Cash 2.08
Free Cash Flow 2.91
Particulars MAR 2021 (Values in Cr)
Net Income -0.03
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 62.45 12.89 122170.95 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.22 23.63 2.85 97.87 40.75 76.00
SHREE PACETRONIX LTD. 134.30 16.03 2.82 50.36 66.10 283.15
TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 81.38 12.26 122170.95 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.25 0.00 -9.55 29.32 30.30 57.48
KOVAI MEDICAL CENTER & HO 5834.80 26.11 4.83 6383.27 5010.00 6725.00

BANDARAM PHARMA PACKTECH LIMIT shareholding pattern

Holding
37.33%
62.66%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BANDARAM PHARMA PACKTECH LIMIT Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
29.59 -0.23 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 29.00
  • 26 Days 28.40
  • 10 Days 28.70
  • 50 Days 28.30
  • 12 Days 28.60
  • 100 Days 28.50
  • 20 Days 28.50
  • 200 Days 30.20
29.55 PIVOT
First Support 29.11 First Resistance 30.11 Second Support 28.55 Second Resistance 30.55 Third Support 28.11 Third Resistance 31.11
RSI 55.92 ADX 24.61 MACD 0.20 Williams % R -66.44 Commodity Channel Index (CCI) 223.69
Date 2026-06-19 Week 3275.00 Same Day 10159.00 Month 1989.00
1 Year 0.41 3 Year 0.22
Over 1 Month
-0.63% down
Over 1 Year
-25.91% down
Over 3 Months
7.60% down
Over 3 Years
1.88% down
Over 6 Months
14.15% down
Over 5 Years
0.00% down

BANDARAM PHARMA PACKTECH LIMIT Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
22 Sep 2025 0.1 Final 22 Sep 2025 Equity shares
20 Sep 2024 0.1 Final 21 Sep 2024 Equity shares
22 Sep 2023 0.1 Final 23 Sep 2023 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bandaram Pharma Packtech Ltd?

Answer Field

Bandaram Pharma Packtech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 29.59 as on Jun 19 2026 03:21 PM.

What is the Market Cap of Bandaram Pharma Packtech Ltd Share?

Answer Field

The market cap of Bandaram Pharma Packtech Ltd for NSE ₹ 0.00 & for BSE ₹ 53.20 as on Jun 19 2026 03:21 PM.

What is the 52 Week High and Low of Bandaram Pharma Packtech Ltd?

Answer Field

The 52 Week High and Low of Bandaram Pharma Packtech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 49.70 and ₹ 22.00.

What is 1 year return for Bandaram Pharma Packtech Ltd?

Answer Field

The 1 year returns on the stock has been -25.91%.

What is the P/E Ratio of Bandaram Pharma Packtech Ltd Share?

Answer Field

As on Jun 19 2026 03:21 PM the price-to-earnings (PE) ratio for Bandaram Pharma Packtech Ltd share is -46.23.

What is the PB ratio of Bandaram Pharma Packtech Ltd Share?

Answer Field

As on Jun 19 2026 03:21 PM, the price-to-book (PB) ratio for Bandaram Pharma Packtech Ltd share is 12.73.

How to Buy Bandaram Pharma Packtech Ltd Share?

Answer Field

You can trade in Bandaram Pharma Packtech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bandaram Pharma Packtech Ltd Share on Bajaj Broking App?

Answer Field

To buy Bandaram Pharma Packtech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bandaram Pharma Packtech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|